Abstract The administration of "active" chondroitin sulfate A (CSA), "active" chondroitin sulfate C (CSC), or mixtures thereof to mammals including humans suffering from cancer, bacterial infections, trauma, irritation, placement of foreign objects, tubes or instruments, or damage of the upper or lower urinary tract, and related transitional cell surfaces to prevent cancer cell implantation or adherence, bacterial infestation or adherence, trauma, irritation, or damage from placement of foreign objects, tubes or instruments in the kidney, renal pelvis, ureter, bladder, urethra and related transitional cell surfaces by the irrigation of said surfaces and/or tubes and instruments with a solution of said drugs or mixtures thereof.
The method which comprises the administration of "active" chondroitin sulfate A (CSA), "active" chondroitin sulfate C (CSC), or mixtures thereof to mammals including humans to the surfaces of the kidney, renal pelvis, ureter, bladder, urethra and related transitional cell surfaces by the irrigation of said surface with a solution of said drugs or mixtures thereof.
Claim 2
Independent Claim
55 words
The method which comprises the administration of "active" chondroitin sulfate A (CSA), "active" chondroitin sulfate C (CSC), or mixtures thereof to mammals including humans to the surfaces of the kidney, renal pelvis, ureter, bladder, urethra and related transitional cell surfaces by the irrigation of said surface with a solution of said drugs or mixtures thereof.
Claim 3
Dependent Claim
18 words
The method of claim 1 wherein the drug is administered in an effective amount as an aqueous solution.
Claim 4
Dependent Claim
14 words
The method of claim 1 wherein said drug is "active" chondroitin sulfate A (CSA).
Claim 5
Dependent Claim
14 words
The method of claim 1 wherein said drug is "active" chondroitin sulfate C (CSC).
Claim 6
Dependent Claim
17 words
The method of claim 1 wherein the irrigation mitigates against adhesion of E-Coli to the bladder surfaces.
Claim 7
Dependent Claim
19 words
The method of claim 1 wherein the irrigation mitigates against the incidence of transitional cell carcinoma in the bladder.